Moderna in final talks to build an mRNA manufacturing and R&D hub in the UK — report
Moderna is reportedly getting ready to take a big step directly into the European arena.
The big biotech, propelled by tens of billions of dollars in sales for its Covid-19 mRNA vaccine, is putting the finishing touches to an agreement with the UK government to build out new R&D and manufacturing facilities in the Golden Triangle — ground zero for the country’s biopharma and scientific complex.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.